Translucency Limited was established to help medical companies solve their complex problems with reimbursement in UK and in 14 other countries across Western Europe. We use scientific and economic evidence to promote successful reimbursement: combining robust academic methodology and commercial experience – we don’t just understand your product, we understand what key decision-makers need to approve it. Then we help you to convince them. Something unique about Translucency: - we bring together the best of academic practice, frontline experience, wide range of contacts, commercial nous and communication skills; - we provide high quality deliverables; - we never miss deadlines; - we work flexibly with client staff and other agency the client may work with; - we are completely committed to our clients’ success. Mark Charny, founder of Translucency: "I set up Translucency in 1999 to address the need to develop robust evidence-based clinical and business cases to support market access and reimbursement for new healthcare technologies in the UK. Since that time Translucency has grown and developed; we now offer services across Western Europe through a team of nationally based reimbursement experts. We bring together scientific, clinical, marketing and communications skills, and with our market knowledge, an appreciation of the business environment, and an extensive network of contacts in healthcare systems, support clients wishing to access new markets and improve their position in existing markets."